Reuters probe spotlights a conflict of interest between biotech investor F-Prime and giant Fidelity
Reuters has done an in-depth spotlight of F-Prime Capital Partners, a prominent biotech venture outfit owned by the billionaire Johnson family, which also founded and manages the mammoth mutual fund Fidelity Investments. The news service concludes that F-Prime’s role in a long lineup of biotech companies blocked Fidelity’s participation in some lucrative deals, while leaving the mutual fund to play a valuable role bolstering the stock F-Prime was able to grab at a bargain price.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.